Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide Plus Dexamethasone Versus Dexamethasone In Newly Diagnosed Multiple Myeloma
NCT00033332Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2002
- Primary completion
- Mar 2006
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of thalidomide in multiple myeloma (MM), sponsored by National Cancer Institute. Started Apr 2002; status: completed.
02
Drugs
thalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00033332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033332.